| Pharmaceutical active ingredients: |
| Methylpentynol |
| Available forms, composition and doses of Noxokratin: |
| N / A |
| Noxokratin medical category: |
| Human:AnticonvulsantsHypnotics and sedatives |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N05CM15 - Methylpentynol |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Noxal | Disulfiram | Unidentified Pharmaceutical Company |
| Noxibiol | Nitroxoline | Unidentified Pharmaceutical Company |
| Noxin | Nitroxoline | Unidentified Pharmaceutical Company |
| Noxiron | Glutethimide | Unidentified Pharmaceutical Company |
| Noxodyn | Thalidomide | Unidentified Pharmaceutical Company |
| Noxyron | Glutethimide | Unidentified Pharmaceutical Company |
| Npvatropine | Homatropine Methylbromide | Unidentified Pharmaceutical Company |
| Nromoson | Ethchlorvynol | Unidentified Pharmaceutical Company |
| N-Toin | Nitrofurantoin | Unidentified Pharmaceutical Company |
| Nu Volt | Methylcobalamin | Unidentified Pharmaceutical Company |